{"id":11106,"date":"2023-05-05T00:00:00","date_gmt":"2023-05-05T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/1970\/01\/01\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/"},"modified":"2025-08-19T08:28:12","modified_gmt":"2025-08-19T13:28:12","slug":"sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/","title":{"rendered":"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA"},"content":{"rendered":"<p>My\u00e9lome Canada est heureux d\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \u00e9t\u00e9 ajout\u00e9 \u00e0 la liste des m\u00e9dicaments rembours\u00e9s par les \u00e9tablissements, en m\u00e9dicaments d\u2019exception, au Qu\u00e9bec! Le Qu\u00e9bec est la premi\u00e8re province canadienne \u00e0 officialiser le remboursement de ce m\u00e9dicament.<\/p>\n<p>Peu de temps apr\u00e8s, soit le 1er mai, l\u2019Alberta a embo\u00eet\u00e9 le pas et approuv\u00e9 remboursement d\u2019isatuximab!<\/p>\n<p><strong>Cet ajout concerne\u202f:&nbsp;<\/strong><\/p>\n<ul>\n<li>Sarclisa (isatuximab) en association avec le carfilzomib et la dexamethasone.&nbsp;<\/li>\n<li>Sarclisa (isatuximab) en association avec la pomalidomide et la dexam\u00e9thasone.&nbsp;<\/li>\n<\/ul>\n<p><a class=\"ButtonSimple\" href=\"https:\/\/www.ramq.gouv.qc.ca\/SiteCollectionDocuments\/professionnels\/medicaments\/tableau-nouveautes-innovateurs\/tableau-nouveautes-innovateurs_2023-04-13.pdf\">Voir la liste des m\u00e9dicaments au QC (en fran\u00e7ais)<\/a><\/p>\n<p><a class=\"ButtonSimple\" href=\"https:\/\/www.albertahealthservices.ca\/assets\/programs\/ps-1025651-drug-benefit-list.pdf\">Voir la liste des m\u00e9dicaments \u00e0 l&rsquo;AB (en anglais)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>My\u00e9lome Canada est heureux d\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \u00e9t\u00e9 ajout\u00e9 \u00e0 la liste des m\u00e9dicaments rembours\u00e9s par les \u00e9tablissements, en m\u00e9dicaments d\u2019exception, au Qu\u00e9bec! Le Qu\u00e9bec est la premi\u00e8re province canadienne \u00e0 officialiser le remboursement de ce m\u00e9dicament. Peu de temps apr\u00e8s, soit le 1er mai, l\u2019Alberta a embo\u00eet\u00e9 le [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[53,50,58,52],"tags":[],"class_list":["post-11106","post","type-post","status-publish","format-standard","hentry","category-actualites-et-evenement","category-news-events","category-nouvelles-de-myelome-canada","category-whats-new-at-myeloma-canada"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"My\u00e9lome Canada est heureux d\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \u00e9t\u00e9 ajout\u00e9 \u00e0 la liste des m\u00e9dicaments rembours\u00e9s par les \u00e9tablissements, en m\u00e9dicaments d\u2019exception, au Qu\u00e9bec! Le Qu\u00e9bec est la premi\u00e8re province canadienne \u00e0 officialiser le remboursement de ce m\u00e9dicament. Peu de temps apr\u00e8s, soit le 1er mai, l\u2019Alberta a embo\u00eet\u00e9 le\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"lemieuxbedard\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"My\u00e9lome Canada |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA | My\u00e9lome Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"My\u00e9lome Canada est heureux d\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \u00e9t\u00e9 ajout\u00e9 \u00e0 la liste des m\u00e9dicaments rembours\u00e9s par les \u00e9tablissements, en m\u00e9dicaments d\u2019exception, au Qu\u00e9bec! Le Qu\u00e9bec est la premi\u00e8re province canadienne \u00e0 officialiser le remboursement de ce m\u00e9dicament. Peu de temps apr\u00e8s, soit le 1er mai, l\u2019Alberta a embo\u00eet\u00e9 le\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-05-05T05:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-08-19T13:28:12+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA | My\u00e9lome Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"My\u00e9lome Canada est heureux d\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \u00e9t\u00e9 ajout\u00e9 \u00e0 la liste des m\u00e9dicaments rembours\u00e9s par les \u00e9tablissements, en m\u00e9dicaments d\u2019exception, au Qu\u00e9bec! Le Qu\u00e9bec est la premi\u00e8re province canadienne \u00e0 officialiser le remboursement de ce m\u00e9dicament. Peu de temps apr\u00e8s, soit le 1er mai, l\u2019Alberta a embo\u00eet\u00e9 le\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#blogposting\",\"name\":\"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\\u00c9BEC ET EN ALBERTA | My\\u00e9lome Canada\",\"headline\":\"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\\u00c9BEC ET EN ALBERTA\",\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#articleImage\"},\"datePublished\":\"2023-05-05T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:12-05:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#webpage\"},\"articleSection\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement, News &amp; Events, Nouvelles de My\\u00e9lome Canada, What's new at Myeloma Canada, Facultatif, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/#listItem\",\"name\":\"News &amp; Events\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/#listItem\",\"position\":2,\"name\":\"News &amp; Events\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/#listItem\",\"name\":\"What's new at Myeloma Canada\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/#listItem\",\"position\":3,\"name\":\"What's new at Myeloma Canada\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#listItem\",\"name\":\"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\\u00c9BEC ET EN ALBERTA\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/#listItem\",\"name\":\"News &amp; Events\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#listItem\",\"position\":4,\"name\":\"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\\u00c9BEC ET EN ALBERTA\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/category\\\/news-events\\\/whats-new-at-myeloma-canada\\\/#listItem\",\"name\":\"What's new at Myeloma Canada\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\",\"name\":\"Myeloma Canada\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"telephone\":\"+18887985771\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/\",\"name\":\"lemieuxbedard\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"lemieuxbedard\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#webpage\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/\",\"name\":\"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\\u00c9BEC ET EN ALBERTA | My\\u00e9lome Canada\",\"description\":\"My\\u00e9lome Canada est heureux d\\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \\u00e9t\\u00e9 ajout\\u00e9 \\u00e0 la liste des m\\u00e9dicaments rembours\\u00e9s par les \\u00e9tablissements, en m\\u00e9dicaments d\\u2019exception, au Qu\\u00e9bec! Le Qu\\u00e9bec est la premi\\u00e8re province canadienne \\u00e0 officialiser le remboursement de ce m\\u00e9dicament. Peu de temps apr\\u00e8s, soit le 1er mai, l\\u2019Alberta a embo\\u00eet\\u00e9 le\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2023\\\/05\\\/05\\\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/lemieuxbedard\\\/#author\"},\"datePublished\":\"2023-05-05T00:00:00-05:00\",\"dateModified\":\"2025-08-19T08:28:12-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"name\":\"Myeloma Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA | My\u00e9lome Canada","description":"My\u00e9lome Canada est heureux d\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \u00e9t\u00e9 ajout\u00e9 \u00e0 la liste des m\u00e9dicaments rembours\u00e9s par les \u00e9tablissements, en m\u00e9dicaments d\u2019exception, au Qu\u00e9bec! Le Qu\u00e9bec est la premi\u00e8re province canadienne \u00e0 officialiser le remboursement de ce m\u00e9dicament. Peu de temps apr\u00e8s, soit le 1er mai, l\u2019Alberta a embo\u00eet\u00e9 le","canonical_url":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#blogposting","name":"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA | My\u00e9lome Canada","headline":"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA","author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/#articleImage"},"datePublished":"2023-05-05T00:00:00-05:00","dateModified":"2025-08-19T08:28:12-05:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#webpage"},"isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#webpage"},"articleSection":"Actualit\u00e9s et \u00e9v\u00e9nement, News &amp; Events, Nouvelles de My\u00e9lome Canada, What's new at Myeloma Canada, Facultatif, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","position":1,"name":"Accueil","item":"https:\/\/myeloma.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/#listItem","name":"News &amp; Events"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/#listItem","position":2,"name":"News &amp; Events","item":"https:\/\/myeloma.ca\/category\/news-events\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/#listItem","name":"What's new at Myeloma Canada"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","name":"Accueil"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/#listItem","position":3,"name":"What's new at Myeloma Canada","item":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#listItem","name":"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/#listItem","name":"News &amp; Events"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#listItem","position":4,"name":"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA","previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/category\/news-events\/whats-new-at-myeloma-canada\/#listItem","name":"What's new at Myeloma Canada"}}]},{"@type":"Organization","@id":"https:\/\/myeloma.ca\/fr\/#organization","name":"Myeloma Canada","url":"https:\/\/myeloma.ca\/fr\/","telephone":"+18887985771","logo":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#organizationLogo"},"image":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author","url":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/","name":"lemieuxbedard","image":{"@type":"ImageObject","@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/46bccf9afb319784ce7a4c49e51be67f2ed9bed19ab02f5f0a63c7aba8c80f06?s=96&d=mm&r=g","width":96,"height":96,"caption":"lemieuxbedard"}},{"@type":"WebPage","@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#webpage","url":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/","name":"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA | My\u00e9lome Canada","description":"My\u00e9lome Canada est heureux d\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \u00e9t\u00e9 ajout\u00e9 \u00e0 la liste des m\u00e9dicaments rembours\u00e9s par les \u00e9tablissements, en m\u00e9dicaments d\u2019exception, au Qu\u00e9bec! Le Qu\u00e9bec est la premi\u00e8re province canadienne \u00e0 officialiser le remboursement de ce m\u00e9dicament. Peu de temps apr\u00e8s, soit le 1er mai, l\u2019Alberta a embo\u00eet\u00e9 le","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/#breadcrumblist"},"author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"creator":{"@id":"https:\/\/myeloma.ca\/fr\/author\/lemieuxbedard\/#author"},"datePublished":"2023-05-05T00:00:00-05:00","dateModified":"2025-08-19T08:28:12-05:00"},{"@type":"WebSite","@id":"https:\/\/myeloma.ca\/fr\/#website","url":"https:\/\/myeloma.ca\/fr\/","name":"Myeloma Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"My\u00e9lome Canada |","og:type":"article","og:title":"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA | My\u00e9lome Canada","og:description":"My\u00e9lome Canada est heureux d\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \u00e9t\u00e9 ajout\u00e9 \u00e0 la liste des m\u00e9dicaments rembours\u00e9s par les \u00e9tablissements, en m\u00e9dicaments d\u2019exception, au Qu\u00e9bec! Le Qu\u00e9bec est la premi\u00e8re province canadienne \u00e0 officialiser le remboursement de ce m\u00e9dicament. Peu de temps apr\u00e8s, soit le 1er mai, l\u2019Alberta a embo\u00eet\u00e9 le","og:url":"https:\/\/myeloma.ca\/fr\/2023\/05\/05\/sarclisa-isatuximab-est-maintenant-couvert-au-quebec-et-en-alberta\/","article:published_time":"2023-05-05T05:00:00+00:00","article:modified_time":"2025-08-19T13:28:12+00:00","twitter:card":"summary_large_image","twitter:title":"SARCLISA (ISATUXIMAB) EST MAINTENANT COUVERT AU QU\u00c9BEC ET EN ALBERTA | My\u00e9lome Canada","twitter:description":"My\u00e9lome Canada est heureux d\u2019annoncer que depuis le 13 avril, Sarclisa (isatuximab) a \u00e9t\u00e9 ajout\u00e9 \u00e0 la liste des m\u00e9dicaments rembours\u00e9s par les \u00e9tablissements, en m\u00e9dicaments d\u2019exception, au Qu\u00e9bec! Le Qu\u00e9bec est la premi\u00e8re province canadienne \u00e0 officialiser le remboursement de ce m\u00e9dicament. Peu de temps apr\u00e8s, soit le 1er mai, l\u2019Alberta a embo\u00eet\u00e9 le"},"aioseo_meta_data":{"post_id":"11106","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-09-18 15:57:40","updated":"2026-04-30 07:09:44","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=11106"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11106\/revisions"}],"predecessor-version":[{"id":31264,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/11106\/revisions\/31264"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=11106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=11106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=11106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}